Literature DB >> 3427782

Characterization of human middle ear mucus glycoprotein in chronic secretory otitis media (CSOM).

J E FitzGerald1, G G Green, F W Stafford, J P Birchall, J P Pearson.   

Abstract

Middle ear effusion was obtained from children with chronic secretory otitis media undergoing myringotomy. The effusions contained about 120 mg/ml non-dialysable solids, of which 18-31% was mucus glycoprotein. The purified mucus glycoprotein had a composition characteristic of other mucus glycoproteins. Amino acid analysis of the glycoprotein indicates a protein core consisting of glycosylated regions resistant to proteolysis and non-glycosylated regions susceptible to proteolysis. Analysis of the mucus glycoprotein by gel filtration on Sepharose 2B showed that reduction caused a decrease in hydrodynamic size and proteolysis caused a further decrease. The difference was confirmed by sedimentation coefficient and viscosity measurements. The reduced glycoprotein had an intrinsic viscosity of 0.113 ml/mg and an S0(20) of 15.2S compared to a value of 0.018 ml/mg and 9.6S for the proteolytically digested glycoprotein. These results suggest a model for this middle ear mucus glycoprotein, in which the native glycoprotein is a large molecular mass polymer maintained by disulphide bridges. These disulphide linked glycoprotein units are broken down into smaller units by proteolysis. The mucus glycoprotein could not be purified completely free from low molecular mass components. A glycoprotein, susceptible to proteolysis Mr 28,000-33,000 co-fractionates with the major high molecular mass mucus glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3427782     DOI: 10.1016/0009-8981(87)90328-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Isolation and partial characterization of rainbow trout (Oncorhynchus mykiss) gill mucin.

Authors:  J S Lumsden; H W Ferguson
Journal:  Fish Physiol Biochem       Date:  1994-01       Impact factor: 2.794

2.  Extending the chinchilla middle ear epithelial model for mucin gene investigation.

Authors:  Joseph E Kerschner; P Khampang; Tina Samuels
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-06-29       Impact factor: 1.675

3.  Heterogeneity in the protein cores of mucins isolated from human middle ear effusions: evidence for expression of different mucin gene products.

Authors:  D A Hutton; F J Fogg; H Kubba; J P Birchall; J P Pearson
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

4.  Characterization of pig colonic mucins.

Authors:  F J Fogg; D A Hutton; K Jumel; J P Pearson; S E Harding; A Allen
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

5.  Mucin gene 19 (MUC19) expression and response to inflammatory cytokines in middle ear epithelium.

Authors:  Joseph E Kerschner; Pawjai Khampang; Christy B Erbe; Alexander Kolker; Joseph A Cioffi
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

6.  Cytokine regulation of mucin secretion in a human middle ear epithelial model.

Authors:  Erica A Samuel; Amy Burrows; Joseph E Kerschner
Journal:  Cytokine       Date:  2007-12-11       Impact factor: 3.861

7.  Gene expression differences in infected and noninfected middle ear complementary DNA libraries.

Authors:  Joseph E Kerschner; Edward Horsey; Azad Ahmed; Christy Erbe; Pawjai Khampang; Joseph Cioffi; Fen Ze Hu; James Christopher Post; Garth D Ehrlich
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.